Viewing Study NCT03788733


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-02-20 @ 3:46 PM
Study NCT ID: NCT03788733
Status: UNKNOWN
Last Update Posted: 2018-12-28
First Post: 2018-12-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Efficacy of Melatonin in the Burning Mouth Syndrome
Sponsor: Universidad de Murcia
Organization:

Study Overview

Official Title: Study of the Efficacy of Melatonin in the Burning Mouth Syndrome
Status: UNKNOWN
Status Verified Date: 2018-12
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: BMS
Brief Summary: Burning mouth ( BMS) syndrome is the oral disorder characterized by an intraoral burning sensation for which no medical or dental cause can be found. The Headache Classification Committee of the International Headache Society (IHS) defines (BMS) as an ''intraoral burning or dysaesthetic sensation, recurring daily for more than 2 hours per day over more than 3 months, without clinically evident causative lesions''. (BMS) is a common, chronic problem that has a negative impact on quality of life.

A wide variety of medications have been proposed for treating (BMS) both topical and systemic. Unfortunately, no treatment seems to offer assured results. Melatonin is a naturally occurring hormone secreted by the pineal gland. It has soporific effects with oral administration and is well tolerated. It enhances sleep Melatonin also may help sleep disturbances associated with (BMS) ; however, this remains to be proven.
Detailed Description: The purpose of this study is to establish whether melatonin can aid in reducing pain improve sleep quality in (BMS)

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: